Skip to main content
. 2010 Jun-Jul;31(6):1003–1009. doi: 10.3174/ajnr.A1971

Table 2:

Doses measured for all protocols on a 320-row scanner (Toshiba Aquilion ONE)

Organ W (T) Noncontrast Head CT Volume
Noncontrast Head CT Incremental
CTP + CTA (Intractranial)
CTA (Neck)
Dose (mGy) Weighted Dose (mSv) Dose (mGy) Weighted Dose (mSv) Dose (mGy) Weighted Dose (mSv) Dose (mGy) Weighted Dose (mSv)
Hemispheres 0.01 31.42 0.31 41.91 0.42 69.91 0.7 3.34 0.03
Skin (scan area) 36.86 42.34 92 3.84
Skin (total) 0.01 19.19 0.19 21.47 0.21 46.49 0.46 3 0.03
Eye lenses 40.23 44.31 44.01 2.39
Pituitary gland 25.24 38.93 52.69 5.3
Bone marrow (scan area) 7.67 12.77 30.17 14.8
Bone marrow (total) 0.12 4.2 0.5 6.97 0.84 15.81 1.9 8.57 1.03
Thyroid gland 0.04 2.54 0.1 3.39 0.14 5.37 0.21 58.6 2.3
Lung 0.12 0.78 0.09 0.4 0.05 0.61 0.07 4.36 0.5
Esophagus 0.04 0.5 0.02 0.63 0.03 0.46 0.02 3.51 0.14
Breast 0.12 1.52 0.18 0.59 0.07 0.98 0.12 2.17 0.26
Liver 0.05 0.77 0.04 0.42 0.02 0.29 0.01 1.16 0.06
Stomach 0.12 0.63 0.08 0.3 0.04 0.29 0.03 1.18 0.14
Ovaries 0.08 0.48 0.04 1.01 0.08 0.42 0.03 0.36 0.03
Lower colon 0.12 0.46 0.06 0.43 0.51 0.23 0.03 0.29 0.03
Bladder 0.04 0.68 0.03 0.59 0.02 0.74 0.03 0.33 0.01
Testes 0.08 0.29 0.02 0.53 0.04 0.43 0.03 0.34 0.03
Effective dose (women) 1.64 2.43 3.61 4.56
Effective dose (men) 1.62 2.39 3.61 4.56